Comments
Loading...

MediWound

MDWDNASDAQ
$19.65
0.462.40%
At Close: -
$19.65
00.00%
After Hours: 4:00 PM EDT
15 minutes delayed
Consensus Rating1
Buy
Highest Price Target1
$36.00
Lowest Price Target1
$7.00
Consensus Price Target1
$19.71

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here

MediWound (NASDAQ:MDWD) Stock, Analyst Ratings, Price Targets, Forecasts

MediWound Ltd has a consensus price target of $19.71 based on the ratings of 7 analysts. The high is $36 issued by Oppenheimer on August 17, 2023. The low is $7 issued by Aegis Capital on March 21, 2022. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on July 16, 2024, May 30, 2024, and March 22, 2024, respectively. With an average price target of $28 between HC Wainwright & Co., there's an implied 42.49% upside for MediWound Ltd from these most-recent analyst ratings.

Analyst Trends and Forecast
0
0
0
0
Mar
0
0
0
0
May
0
0
0
0
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

HC Wainwright & Co.
Oppenheimer
Cowen & Co.
Maxim Group
Wells Fargo

1calculated from analyst ratings

Analyst Ratings for MediWound

Buy NowGet Alert
07/16/2024Buy Now42.49%HC Wainwright & Co.
Swayampakula Ramakanth
$28 → $28ReiteratesBuy → BuyGet Alert
05/30/2024Buy Now42.49%HC Wainwright & Co.
Swayampakula Ramakanth
$28 → $28ReiteratesBuy → BuyGet Alert
03/22/2024Buy Now42.49%HC Wainwright & Co.
Swayampakula Ramakanth
ReiteratesBuy → BuyGet Alert
01/16/2024Buy Now42.49%HC Wainwright & Co.
Swayampakula Ramakanth
$26 → $28MaintainsBuyGet Alert
11/22/2023Buy Now32.32%HC Wainwright & Co.
Swayampakula Ramakanth
→ $26ReiteratesBuy → BuyGet Alert
09/21/2023Buy Now32.32%HC Wainwright & Co.
Swayampakula Ramakanth
$23 → $26MaintainsBuyGet Alert
08/17/2023Buy Now83.21%Oppenheimer
Francois Brisebois
$63 → $36MaintainsOutperformGet Alert
08/17/2023Buy Now17.05%HC Wainwright & Co.
Swayampakula Ramakanth
→ $23ReiteratesBuy → BuyGet Alert
05/31/2023Buy Now220.61%Oppenheimer
Francois Brisebois
→ $63ReiteratesOutperform → OutperformGet Alert
05/31/2023Buy Now17.05%HC Wainwright & Co.
Swayampakula Ramakanth
→ $23ReiteratesBuy → BuyGet Alert
03/17/2023Buy Now17.05%HC Wainwright & Co.
Swayampakula Ramakanth
→ $23Reiterates → BuyGet Alert
01/04/2023Buy Now17.05%HC Wainwright & Co.
Swayampakula Ramakanth
$5.5 → $23MaintainsBuyGet Alert
12/30/2022Buy Now27.23%Cowen & Co.
Joshua Jennings
$6 → $25MaintainsOutperformGet Alert
12/22/2022Buy Now27.23%Maxim Group
Michael Okunewitch
→ $25Initiates → BuyGet Alert
12/21/2022Buy Now220.61%Oppenheimer
Francois Brisebois
$9 → $63MaintainsOutperformGet Alert
11/16/2022Buy Now-72.01%HC Wainwright & Co.
Swayampakula Ramakanth
$42 → $38.5MaintainsBuyGet Alert
07/18/2022Buy Now-64.38%Oppenheimer
Francois Brisebois
→ $49Assumes → OutperformGet Alert
05/18/2022Buy Now-59.29%Wells Fargo
Jacob Hughes
$49 → $56MaintainsOverweightGet Alert
03/21/2022Buy Now-64.38%Aegis Capital
Nathan Weinstein
$63 → $49MaintainsBuyGet Alert
08/17/2021Buy Now-54.2%Aegis CapitalMaintainsBuyGet Alert
08/11/2021Buy Now-66.92%HC Wainwright & Co.
Swayampakula Ramakanth
MaintainsBuyGet Alert

FAQ

Q

What is the target price for MediWound (MDWD) stock?

A

The latest price target for MediWound (NASDAQ:MDWD) was reported by HC Wainwright & Co. on July 16, 2024. The analyst firm set a price target for $28.00 expecting MDWD to rise to within 12 months (a possible 42.49% upside). 8 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for MediWound (MDWD)?

A

The latest analyst rating for MediWound (NASDAQ:MDWD) was provided by HC Wainwright & Co., and MediWound reiterated their buy rating.

Q

When was the last upgrade for MediWound (MDWD)?

A

There is no last upgrade for MediWound

Q

When was the last downgrade for MediWound (MDWD)?

A

There is no last downgrade for MediWound.

Q

When is the next analyst rating going to be posted or updated for MediWound (MDWD)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MediWound, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MediWound was filed on July 16, 2024 so you should expect the next rating to be made available sometime around July 16, 2025.

Q

Is the Analyst Rating MediWound (MDWD) correct?

A

While ratings are subjective and will change, the latest MediWound (MDWD) rating was a reiterated with a price target of $28.00 to $28.00. The current price MediWound (MDWD) is trading at is $19.65, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.